Lyell Immunopharma: Q3 Earnings Snapshot

SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Lyell Immunopharma Inc. (LYEL) on Wednesday reported a loss of $45.5 million in its third quarter.

On a per-share basis, the South San Francisco, California-based company said it had a loss of $1.86.

The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $2.06 per share.

The biotechnology firm posted revenue of $3,000 in the period.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LYEL at https://www.zacks.com/ap/LYEL